Chen Xiancheng, Gan Weidong, Ye Qing, Yang Jun, Guo Hongqian, Li Dongmei
Department of Urology, Affiliated Drum Tower Hospital, College of Medicine, Nanjing University, Nanjing 210008, China.
Email:
Zhonghua Yi Xue Za Zhi. 2014 Dec 16;94(46):3675-7.
To explore the value of self-designed fluorescent in situ hybridization (FISH) polyclonal break-apart probes specific for TFE3 gene in the diagnosis of Xp11.2 translocation renal cell carcinoma.
All tissue samples were collected from 2006 to 2013, including Xp11.2 translocation renal cell carcinoma (n = 10), renal clear cell carcinoma (n = 10) and renal papillary cell carcinoma (n = 10). FISH was conducted for paraffin-embedded tumor tissue sections with probes. The types of fluorescence were observed by fluorescent microscopy to determine the existence or non-existence of translocated TFE3 gene.
All sections were successfully probed. The split red and green signals within a single nucleus were detected simultaneously in 9 cases of Xp11.2 translocation renal cell carcinoma as diagnosed by traditional pathological and immunohistochemical methods. And it was consistent with the initial diagnosis. Detection of fusion signal in 1/10 and negative FISH result did not conform to the initial diagnosis. The fluorescent types of renal clear cell carcinoma and renal papillary cell carcinoma were all fusion signals. FISH tests were negative for renal clear and papillary cell carcinomas.
Xp11.2 translocation renal cell carcinomas diagnosed by traditional pathological and immunohistochemical methods are sometimes misdiagnosed. Detecting the translocation of TFE3 gene with FISH polyclonal break-apart probes is both accurate and reliable for diagnosing Xp11.2 translocation renal cell carcinoma.
探讨自行设计的针对TFE3基因的荧光原位杂交(FISH)多克隆分裂探针在Xp11.2易位性肾细胞癌诊断中的价值。
收集2006年至2013年的所有组织样本,包括Xp11.2易位性肾细胞癌(n = 10)、肾透明细胞癌(n = 10)和肾乳头状细胞癌(n = 10)。用探针进行石蜡包埋肿瘤组织切片的FISH检测。通过荧光显微镜观察荧光类型,以确定是否存在易位的TFE3基因。
所有切片均成功进行探针检测。在9例经传统病理和免疫组化方法诊断为Xp11.2易位性肾细胞癌的病例中,同时检测到单个细胞核内的红色和绿色分裂信号,且与初步诊断一致。1/10的病例检测到融合信号,FISH阴性结果与初步诊断不符。肾透明细胞癌和肾乳头状细胞癌的荧光类型均为融合信号,肾透明细胞癌和乳头状细胞癌的FISH检测均为阴性。
经传统病理和免疫组化方法诊断的Xp11.2易位性肾细胞癌有时会被误诊。用FISH多克隆分裂探针检测TFE3基因易位对诊断Xp11.2易位性肾细胞癌准确可靠。